Developments Profound Medical in collaboration with Siemens Healthineers to expand access to the TULSA procedure to treat prostate disease Profound Medical (NASDAQ:PROF; TSX:PRN) announced a non-exclusive collaboration with Siemens Healthineers (XETRA:SHL) aimed at laying the groundwork for Profound to begin marketing a complete therapeutics solution... February 28, 2024